Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Avanti Gupta joins EQ Investors: Annual Sustainability Summit 2024

Avanti Gupta, Investor Engagement Manager at the Access to Medicine Foundation, will speak on healthcare investment and engagement at the EQ Investors: Annual Sustainability Summit 2024, providing an opportunity to educate investors on how to use the Foundation’s resources to engage with pharmaceutical companies.

Date

14 November 2024

Location

London, UK

The EQ Investors: Annual Sustainability Summit 2024 will convene asset managers, sustainability leaders and representatives across industries to discuss challenges and opportunities in sustainable investing. 

Now in its third year, the event provides a forum to share their successful examples and challenges in creating investment portfolios that align with sustainable development goals, including climate action, global health and other social issues. 

During the “Healthcare – Demystifying pharma” section of the event, which will focus on opportunities within the health sector, speakers will include: 

  • Damien Lardoux, Head of Impact Investing (EQ), Novo Nordisk 

  • Frederik Taylor Pitter, Investor Relations Manager, Novo Nordisk 

  • Avanti Gupta, Investor Engagement, Access to Medicine Foundation 

In her presentation, “Bringing light to leaders and laggards,” Avanti will share how investors can utilise the Foundation’s research and reports to deepen their understanding of complex access-to-medicine issues and improve their engagement with pharmaceutical companies. 

She will also preview relevant insights from the 2024 Access to Medicine Index – set to be released the week following the event – which scores and ranks pharmaceutical companies on their performance on priority access-to-medicine metrics. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Research

The Methodology for the 2024 Access to Medicine Index

10 October 2023
Research

Patient centricity: How is the pharma industry addressing patient reach?

10 September 2024
Media

How investors can bolster global health equity while generating long-term value

12 February 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved